PHILADELPHIA (GenomeWeb) – At the American Association for Clinical Chemistry annual meeting here today, BioRad Laboratories announced that it has received 510(k)clearance from the US Food and Drug Administration for a multi-analyte quality control designed to monitor the performance of in vitro nucleic acid tests for viral load assays used in the diagnosis of human immunodeficiency type 1, hepatitis B, and hepatitis C viruses.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.